These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 2872912)

  • 1. The treatment of Raynaud's phenomenon.
    Dowd PM
    Br J Dermatol; 1986 May; 114(5):527-33. PubMed ID: 2872912
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacological treatment of Raynaud's phenomenon with special reference to calcium-entry blockers.
    Nilsson H
    Acta Pharmacol Toxicol (Copenh); 1986; 58 Suppl 2():137-49. PubMed ID: 2872769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of Raynaud's phenomenon.
    Wollersheim H; van Zwieten PA
    Eur Heart J; 1993 Feb; 14(2):147-9. PubMed ID: 8095453
    [No Abstract]   [Full Text] [Related]  

  • 4. Raynaud's phenomenon.
    Grisanti JM
    Am Fam Physician; 1990 Jan; 41(1):134-42. PubMed ID: 1967198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of Raynaud's phenomenon].
    Lazareth I
    Ann Dermatol Venereol; 1987; 114(8):1035-8. PubMed ID: 2892456
    [No Abstract]   [Full Text] [Related]  

  • 6. [An update on the management of Raynaud's phenomenon].
    Rodríguez-García JL
    An Med Interna; 1991 Oct; 8(10):513-20. PubMed ID: 1751694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Calcium antagonists and Raynaud's phenomenon].
    Hachulla E; Devulder B
    Therapie; 1993; 48 Spec No():707-11. PubMed ID: 8091357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical practice. Raynaud's Phenomenon.
    Wigley FM
    N Engl J Med; 2002 Sep; 347(13):1001-8. PubMed ID: 12324557
    [No Abstract]   [Full Text] [Related]  

  • 9. Raynaud's phenomenon. An update.
    Coffman JD
    Hypertension; 1991 May; 17(5):593-602. PubMed ID: 2022404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The treatment of Raynaud's phenomenon.
    Seibold JR; Allegar NE
    Clin Dermatol; 1994; 12(2):317-21. PubMed ID: 8076271
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of Raynaud's phenomenon.
    García-Carrasco M; Jiménez-Hernández M; Escárcega RO; Mendoza-Pinto C; Pardo-Santos R; Levy R; Maldonado CG; Chávez GP; Cervera R
    Autoimmun Rev; 2008 Oct; 8(1):62-8. PubMed ID: 18692160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Raynaud's syndrome: current trends.
    Belch JJ; Sturrock RD
    Br J Rheumatol; 1983 Feb; 22(1):50-5. PubMed ID: 6337664
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of Raynaud's phenomenon].
    Levy Y; Shoenfeld Y
    Harefuah; 1993 Mar; 124(5):288-91. PubMed ID: 8098699
    [No Abstract]   [Full Text] [Related]  

  • 14. Raynaud's vasospasm.
    Memon AS
    Hosp Pract (Off Ed); 1983 May; 18(5):141, 144, 149-50. PubMed ID: 6188674
    [No Abstract]   [Full Text] [Related]  

  • 15. [Management of Raynaud's phenomenon].
    Boccalon H; Monin A; Reggy M
    Soins Cardiol; 1986 Apr; (38):27-9. PubMed ID: 3637023
    [No Abstract]   [Full Text] [Related]  

  • 16. [Raynaud's phenomenon in children].
    Quartier P
    Arch Pediatr; 2004 Jan; 11(1):74-7. PubMed ID: 14700771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Medical treatment of the Raynaud phenomenon].
    Zicot M
    Phlebologie; 1987; 40(1):47-9. PubMed ID: 3033711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New treatments for Raynaud's syndrome].
    Bellucci S; Kedra W; Ajzenberg N; Tobelem G; Caen J
    Nouv Rev Fr Hematol (1978); 1988; 30(1-2):103-7. PubMed ID: 3290833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Raynaud's syndrome, 2011].
    Takáts A; Garai I; Papp G; Hevér T; Csiki E; András C; Csiki Z
    Orv Hetil; 2012 Mar; 153(11):403-9. PubMed ID: 22390864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacotherapy of Raynaud's phenomenon.
    Belch JJ; Ho M
    Drugs; 1996 Nov; 52(5):682-95. PubMed ID: 9118818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.